Health-related quality of life and economic burden to smoking behaviour among Canadians.
Economic burden
Health-related quality of life
Smoking
Journal
Canadian journal of public health = Revue canadienne de sante publique
ISSN: 1920-7476
Titre abrégé: Can J Public Health
Pays: Switzerland
ID NLM: 0372714
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
06
11
2018
accepted:
27
06
2019
pubmed:
8
9
2019
medline:
12
3
2020
entrez:
8
9
2019
Statut:
ppublish
Résumé
The objectives of this study were to: (1) examine whether the smoking status of the Canadian population is associated with a reduction in health-related quality of life (HRQoL); (2) calculate the overall economic burden of loss in HRQoL using a commonly accepted $100,000 willingness-to-pay (WTP) threshold to gain one quality-adjusted life year (QALY); and (3) calculate the loss of HRQoL over a lifetime. We used the 2015 Canadian Community Health Survey. The variations in HRQoL were estimated using a multivariable generalized linear model. Total expected lifetime QALYs lost due to smoking were calculated by compounding the annual adjusted health utility loss associated with smoking across a respondent's remaining years of life expectancy stratified by age. A discount rate of 1.5% was applied to the analysis based on recent analysis of the costs of borrowing in Canada. Smoking is significantly associated with HRQoL loss. This study demonstrated that smoking is associated with a 0.05 and 0.01 reduction in Health Utilities Index Mark 3 (HUI3) score for current and former smokers, which also corresponds to a loss of 0.66 quality-adjusted life years in average, and also is associated with substantial individual and societal economic cost. The total lifetime economic burden of HUI3 loss per smoker was $65,935, yielding in the aggregate a societal burden of $1068.88 billion in the study population. Tobacco control, prevention and intervention not only will improve HRQoL but also will generate social returns on investment.
Identifiants
pubmed: 31493265
doi: 10.17269/s41997-019-00244-x
pii: 10.17269/s41997-019-00244-x
pmc: PMC6964578
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
533-541Commentaires et corrections
Type : CommentIn
Références
N Engl J Med. 2014 Aug 28;371(9):796-7
pubmed: 25162885
COPD. 2015 Jun;12(3):276-86
pubmed: 25207639
Addiction. 1997 Jan;92(1):15-26
pubmed: 9060194
BMJ. 2000 May 6;320(7244):1240-3
pubmed: 10797032
J Public Health Med. 1997 Sep;19(3):268-73
pubmed: 9347449
Am J Prev Med. 2010 Feb;38(2):138-44
pubmed: 20117569
Aust N Z J Public Health. 2013 Dec;37(6):516-9
pubmed: 24892149
Med Care. 2002 Feb;40(2):113-28
pubmed: 11802084
Prev Med. 2006 Mar;42(3):206-9
pubmed: 16443264
Eur J Public Health. 2005 Jun;15(3):262-9
pubmed: 15755781
Gut. 2015 Aug;64(8):1268-76
pubmed: 25183203
Int J Public Health. 2013 Dec;58(6):913-25
pubmed: 23436022
J Clin Epidemiol. 2002 Jan;55(1):67-76
pubmed: 11781124
BMC Public Health. 2012 Mar 19;12:203
pubmed: 22429454
Prev Med. 1999 Sep;29(3):139-44
pubmed: 10479599
Health Qual Life Outcomes. 2003 Oct 16;1:54
pubmed: 14613568
Qual Life Res. 2000;9(6):591-601
pubmed: 11236850
Am J Prev Med. 2005 Feb;28(2):182-7
pubmed: 15710274